Availability of the Essential Medicines is Community Pharmacies: A Cross-Sectional Study

Abstract

Corresponding author: Jaykaran Charan, Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan 342005, India. E-mail: dr.jaykaran78@gmail.com World Health Organization (WHO) defines essential drugs or medicines as “those drugs that satisfy the healthcare needs of majority of the population; they should therefore be available at all times in adequate amounts and in appropriate dosage forms, at a price the community can afford.”1 Since 1975, the WHO has taken over its role on the essential drugs, which was initially a mere concept to a well-established policy.2 In the year 1977, the WHO decided to make this concept more concrete, and thus prepared and published a model list of essential drugs which had around 200 drugs including the vaccines.3 The WHO model of the essential medicine list (EML) thus came into force in 1977 and is being updated every two years since then.4 The current version of the list is in its 21st edition, and the essential medicine list for children is in its seventh edition which was last updated in the month of June in the year 2019.5 In the case of India, the first EML was published in 1996.3 The latest list was published in 2015 with 376 drugs.6 Many states also have their respective EML. Rajasthan is one among the many states having their EML. The current EML for the state of Rajasthan was published in the year 2019 which comprises 608 drugs.7 Looking at the importance of EML for patient care, it is important to ascertain that these drugs are available easily at community pharmacies at affordable cost. As per the various previous published studies, many drugs from EML are not available in community and hospital pharmacies.8–11 A study done by Rathish et al.8 in a rural Sri Lankan district found out that there was a discrepancy in the availability of essential medicines among the base hospitals and central dispensary. It was also noted that the availability of drugs for different clinical conditions also varied considerably.8 Another study done by Chandani et al.9 in Ethiopia, Malawi, and Rwanda stated that the availability of drugs was much fragile in different countries.9 Tripathi et al.10 conducted a study in the state of Chhattisgarh, India, and found out that about 58% of the prescribed medicines were found to be available, and by improving certain factors like the state financial resources, supply chain, and encouraging physicians in prescribing these drugs would certainly lead to the improvement in their overall availability.10 The drugs from the EML should not only be easily available but also be obtainable at an affordable price. A study was done by Faruqui et al.11 in New Delhi, India, on the availability of drugs for chronic illnesses found out that the mean availability did not meet the 80% criteria as proposed by the WHO over all facilities.11 It is very clear that there is an unavailability of robust data related to the availability of different medicines from the EML. This data is very important to know the current status of the availability of essential medicines, and would also prove to be useful in policy-making decisions. Hence, this study was conducted with the aim to assess the availability of essential medicines from central and state lists of essential medicines in community pharmacies. This study was a cross-sectional survey. It was conducted in the community, where private pharmacies were approached with the list of essential medicines (both central and state) and the availability of these medicines were asked. These pharmacies were located near the government and private hospitals. Pharmacies attached to any specific hospitals and government-backed generic drug stores were not included in the study. This study was approved by the